Mechanism of Hypoxia-Activated MiR-194 /FoxO3a Inducing Glycolytic Metabolism Reprogramming in Gastric Precancerous Lesions

Abstract Background: Early diagnosis and treatment of gastric precancerous lesions (GPL) are key factors for reducing the incidence and morbidity of gastric cancer. The study aimed to examine GPL in mice induced by MNU and to illustrate the underlying mechanisms of tumorigenesis.Methods: In this study, we utilized an in vivo MNU (N-methyl-N-nitroso-urea)-induced GPL mouse model, Histopathological changes of the gastric mucosa were observed by Hematoxylin and Eosin (H&E-stain) and alcian blue (AB-PAS-stain); The level of miR-194-5p in the gastric mucosa were determined by real‐time polymerase chain reaction; We used transmission electron microscopy to observe the effects of MNU on gastric chief cells and parietal cells; We performed immunohistochemical detection of HIF-1α, vWF, Ki-67 and P53, while the changes in protein expression of key genes in LKB1-AMPK and AKT-FoxO3 signaling pathways were detected by western blot analysis.Results: We demonstrated that miR-194-5p expression was upregulated under hypoxia in GPL gastric tissues, and that a high miR-194-5p expression level closely related with tumorigenesis. Mechanistically, miR-194-5p exerted the acceleration of activities related to metabolic reprogramming through LKB1-AMPK and AKT-FoxO3 pathways. Furthermore, similar to miR-194-5p, high expression levels of AMPK and AKT were also related to the metabolic reprogramming of GPL. Moreover, we revealed the correlation between the expression levels of miR-194-5p, p-AMPKα, p-AKT, and FoxO3a. Conclusions: These findings suggest that miR-194-5p/FoxO3 pathway is important for the reversal of metabolic reprogramming in GPL. Thus, exploring strategies to regulate the miR-194-5p/FoxO3a pathway may provide an efficient strategy for the prevention and treatment of GPL.